" class="no-js "lang="en-US"> David Coman - Medtech Alert
Tuesday, September 02, 2025
David Coman

David Coman

About David Coman

Results-driven business leader, pioneering new paths to unlock latent growth potential

Revenue improvement as divisional president or GM (over a 3-4 year period):
• $0 – $35 Million: Digital Health Professional Services
• $0 – $50 Million: Mobile Virtual Network Operator

Revenue improvement as senior strategy executive (over a 2-4 year period):
• $315 Million – $650 Million: Life Science Technology
• $3 Billion – $4+ Billion: Pharmaceutical Contract Research & Sales (CRO/CSO)
• $0 – $1 Billion: Personal Communications Service (PCS)

Education
• MBA, Kellogg Graduate School, Northwestern University
• BA, Michigan State University

Related Story

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

September 8 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]